Loss of heterozygosity on chromosome arm 13q in larynx cancer patients: Analysis of tumor, margin and clinically unchanged mucosa

Medical Science Monitor

Volumn 10, Issue 6, 2004, Pages

  Szukała, Katarzyna ^a   Brieger, Jürgen ^b   Bruch, Katharina ^b   Biczysko, Wiesława ^c   Wierzbicka, Małgorzata ^c   Szyfter, Witold ^c   Szyfter, Krzysztof ^a,c  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Field cancerization; Relapse; Second primary tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHROMOSOME 13Q; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LARYNX CANCER; LARYNX MUCOSA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; ONCOGENE; PREDICTION; SECOND CANCER;

ADULT; AGED; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 13; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUCOUS MEMBRANE;

EID: 3042817605     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Sokic SI, Adanja BJ, Marinkovic JP, Vlajinac HD: Risk factors for laryngeal cancer. Eur J Epidemiol, 1995; 11: 431-33
2. Zatoński W, Tyczyński J: Epidemiologia nowotworów złośliwych w Polsce w 15-leciu 1980-1994. Centrum Onkologii - Instytut Marii Curie-Skłodowskiej, Warszawa, 1997
3. Tabor MP, Brakenhoff RH, van Houten V et al: Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res, 2001; 7: 1523-32
4. Beder LB, Gunduz M, Ouchida M et al: Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest, 2003; 83: 99-105
5. Wynder EL, Bross IJ, Day E: Etiological approach to the cancer of the larynx. JAMA, 1956; 160: 1384
6. Maier H, Tisch M: Epidemiology of laryngeal cancer: results of the Heidelberg case-control study. Acta Otolaryngol. Suppl. 1997; 527: 160
7. Jones AS, Morar P, Phillips DE et al: Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer, 1995; 75: 1343-53
8. Kuczyński B, Pruszewicz M, Wierzbicka M: Incidence of second primary malignant neoplasms in patients treated for laryngeal cancer. Otolaryng Pol, 1995; XLIX Suppl. 20: 323-28
9. Slaughter D, Southwick H, Smejkal W: Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer, 1953; 6: 953-71
10. Lydiatt WM, Anderson PE, Bazzana T et al: Molecular support for field cancerization in the head and neck. Cancer, 1998; 82: 1376-80
11. Jin Ch, Jin Y, Wennerberg J et al: Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogen, 2002; 132: 85-96
12. Nagai MA: Genetic alterations in head and neck squamous cell carcinomas. Braz J Med Biol Res, 1999; 32: 897-904
13. Gollin SM: Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head & Neck, 2001; 238-52
14. Wistuba II, Behrens C, Virmani AK et al: Allelic losses at chromosome 8p21-28 are early and frequent events in the pathogenesis of lung cancer. Cancer Res, 1999; 59: 1973-9
15. Miyakis S, Spandidos DA: Allelic loss in breast cancer. Cancer Detect Prev, 2002; 26: 426-34
16. Thomas NA, Neville PJ, Baxter SW, Campbell IG: Genetic analysis of benign ovarian tumors. Int J Cancer, 2003; 105: 499-505
17. Goel A, Arnold CN, Niedźwiecki D et al: Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res, 2003; 63: 1608-14
18. Ah-See KW, Cooke TG, Pickford IR et al: An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res, 1994; 54: 1617-21
19. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res, 1994; 54: 1152-5
20. Rowley H, Jones A, Spandidos D, Field J: Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch. Otolaryngol. Head Neck Surg, 1996; 122: 497-501
21. Califano J, van der Riet P, Clayman G et al: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res, 1996; 56: 2488-92
22. Mao L, Lee JS, Fan YH et al: Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med, 1996; 2: 682-85
23. Partridge M, Peteromichelakis S, Phillips E et al: A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res, 2000; 60: 3893-98
24. Försti A, Louhelainen J, Söderberg M et al: Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur J Cancer, 2001; 37: 1372-80
25. Van der Riet P, Nawroz H, Hruban RH et al: Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res, 1994; 54: 1156-58
26. Roz L, Chu LW, Porter S et al: Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res, 1996; 56: 1228-31
27. Guo Z, Yamaguchi K, Sanchez-Cespedes M et al: Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res, 2001; 7: 1963-68
28. Dotzenrath C, Teh BT, Farnebo F et al: Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocr Metab, 1996; 81: 3194-6
29. Eiriksdottir G, Johannesdottir G, Ingvarsson S et al: Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer, 1998; 34: 2076-81
30. Dolan K, Garde J, Gosney J et al: Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Brit J Cancer, 1998; 78: 950-57
31. Lai S, Benedict WF, Silver SA, El-Naggar AK: Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. Hum Pathol, 1997; 28: 693-97
32. Wada T, Louhelainen J, Hemminki K et al: Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. Clin Cancer Res, 2000; 6: 610-15
33. Manderson EN, Presneau N, Provencher D et al: Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Mol Carcinogen, 34: 78-90
34. Dong JT, Boyd JC, Frierson HF Jr: Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate. 2001; 49: 166-71
35. Yoo GH, Xu HJ, Brennan JA et al: Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res, 1994; 54: 4603-606
36. Maestro R, Piccinin S, Doglioni C et al: Chromosome 13q deletion mapping in head and neck squamous cell carcinomas - identification of two distinct regions of preferential loss. Cancer Res, 1996; 56: 1146-50
37. Gupta VK, Schmidt AP, Pashia ME, Sunwoo JB, Scholnick SB: Multiple regions of deletion on chromosome arm 13q in head and neck squamous cell carcinoma. Int J Cancer, 1999; 84: 453-57
38. Jones A: Tumour suppressor genes and head and neck cancer. In: Kitamura K, Steel KP, editors. Genetics in Otorhinolaryngology. Adv.Otorhinolaryngol. Basel, Karger; 2000, 56: 249-60
39. Wang Y, Hung S-Ch, Linn JF, Steiner G, Glazer AN, Sidransky D, Mathies R: Microsatellite-based cancer detection using capillary array electrophoresis and energy-transfer fluorescent primers. Electrophoresis, 1997; 18: 1742-49
40. Kujawski M, Rydzanicz M, Sarlomo-Rikala M, Szyfter K: Rearrangements involving the 13q chromosome arm committed to the progression of laryngeal squamous cell carcinoma. Cancer Genet Cytogen, 2002; 137: 54-58
41. Sanchez-Cespedes M, Okami K, Cairns P, Sidransky D: Molecular analysis of the candidate tumor suppressor gene ING 1 in human head and neck tumors with 13q deletions. Gene Chromosome Canc, 2000; 27: 319-22
42. Fiedler W, Hoppe C, Schimmel B et al: Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Int J Mol Med, 2002; 9: 417-23
43. Piccinin S, Gasparotto D, Vukosavljevic T et al: Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena. Brit J Cancer, 1998; 78: 1147-51
44. Rosin MP, Cheng X, Poh C et al: Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res, 2000; 6: 357-62